Abstract
Generating real world evidence (RWE) from prospective longitudinal studies like registries can provide critical data to demonstrate safety and efficacy, especially long-term, of MS treatments. The objective is to review US registries for MS, as potential RWD sources for collaborative research to assess the clinical effectiveness of MS therapies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
